Premium
Liver transplantation in a patient after COVID‐19 – Rapid loss of antibodies and prolonged viral RNA shedding
Author(s) -
Niess Hanno,
Börner Nikolaus,
Muenchhoff Maximilian,
Khatamzas Elham,
Stangl Manfred,
Graf Alex,
Girl Philipp,
Georgi Enrico,
Koliogiannis Dionysios,
Denk Gerald,
Irlbeck Michael,
Werner Jens,
Guba Markus
Publication year - 2021
Publication title -
american journal of transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.89
H-Index - 188
eISSN - 1600-6143
pISSN - 1600-6135
DOI - 10.1111/ajt.16349
Subject(s) - convalescence , medicine , viral shedding , covid-19 , liver transplantation , transplantation , antibody , immunity , immunology , virology , immune system , infectious disease (medical specialty) , disease , outbreak
Abstract To date, little is known about the duration and effectiveness of immunity as well as possible adverse late effects after an infection with SARS‐CoV‐2. Thus it is unclear, when and if liver transplantation can be safely offered to patients who suffered from COVID‐19. Here, we report on a successful liver transplantation shortly after convalescence from COVID‐19 with subsequent partial seroreversion as well as recurrence and prolonged shedding of viral RNA.